In-patient SCC TMS

Part of paid clinical trials in Los Angeles, California.

Sponsor
University of California, Los Angeles
Study ID
NCT05645575
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 65 Years
Healthy Volunteers
Not accepted

Interventions

  • Open-label TMS — DEVICE
    Customized, Open-Label Transcranial Magnetic Stimulation

Study Details

The investigators are studying the feasibility, safety, and tolerability of administering accelerated repetitive Transcranial magnetic stimulation(a-rTMS) at frequencies other than standard 10 Hz for in-patient Subjects diagnosed with Major Depressive Disorder. Participants will be recruited from the Resnick Neuropsychiatric Hospital. This study will enroll 30 participants who will undergo up to three brain activity recordings, one MRI scan, one TMS procedure to determine the appropriate frequency and intensity for treatment, daily symptom assessments, and 25 TMS treatments. Participants will be asked to participate for up to 2 weeks.

Key Dates

Start date
Apr 1, 2025
Status verified
Sep 2025
Primary completion
Feb 22, 2027
Completion
Feb 22, 2027

Study Design

Enrollment
30 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Open-label TMS

Primary Outcome Measure

Treatment Efficacy as Measured by Change in Inventory of Depressive Symptoms (Self-Report) at Baseline and Final Visit [ Time Frame: 2 Weeks (Baseline and Final Visit) ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
UCLA TMS Service and Research ServiceLos AngelesCalifornia90024
Nikita Vincecruz, BS

Find similar trials in Los Angeles, CA

By condition
Depression
By specialty
PsychiatryMental healthBehavioral health
By research site
UCLA TMS Service and Research Service· Los Angeles, CA

Related Studies